Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19734009rdf:typepubmed:Citationlld:pubmed
pubmed-article:19734009lifeskim:mentionsumls-concept:C1273518lld:lifeskim
pubmed-article:19734009lifeskim:mentionsumls-concept:C1425272lld:lifeskim
pubmed-article:19734009lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:19734009lifeskim:mentionsumls-concept:C0751122lld:lifeskim
pubmed-article:19734009lifeskim:mentionsumls-concept:C1843571lld:lifeskim
pubmed-article:19734009lifeskim:mentionsumls-concept:C1850419lld:lifeskim
pubmed-article:19734009lifeskim:mentionsumls-concept:C1970036lld:lifeskim
pubmed-article:19734009lifeskim:mentionsumls-concept:C1420484lld:lifeskim
pubmed-article:19734009pubmed:issue1lld:pubmed
pubmed-article:19734009pubmed:dateCreated2009-11-5lld:pubmed
pubmed-article:19734009pubmed:abstractTextSevere myoclonic epilepsy of infancy (SMEI) or Dravet syndrome (DS) is a distinctive epilepsy syndrome often associated with de novo mutations in the SCN1A gene. However, 25-30% patients with SMEI/DS are negative for SCN1A mutation screening, suggesting that other molecular mechanisms may account for these disorders. Given the overlapping and heterogeneous clinical features of CDKL5- and ARX-related epilepsies and SMEI/DS, we postulated that CDKL5 mutations in females and ARX mutations gene in males may be associated with early onset seizures forms of SMEI/DS.lld:pubmed
pubmed-article:19734009pubmed:languageenglld:pubmed
pubmed-article:19734009pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19734009pubmed:citationSubsetIMlld:pubmed
pubmed-article:19734009pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19734009pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19734009pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19734009pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19734009pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19734009pubmed:statusMEDLINElld:pubmed
pubmed-article:19734009pubmed:monthNovlld:pubmed
pubmed-article:19734009pubmed:issn1872-6844lld:pubmed
pubmed-article:19734009pubmed:authorpubmed-author:DulacOlivierOlld:pubmed
pubmed-article:19734009pubmed:authorpubmed-author:HéronDelphine...lld:pubmed
pubmed-article:19734009pubmed:authorpubmed-author:ChellyJamelJlld:pubmed
pubmed-article:19734009pubmed:authorpubmed-author:BienvenuThier...lld:pubmed
pubmed-article:19734009pubmed:authorpubmed-author:BeldjordCheri...lld:pubmed
pubmed-article:19734009pubmed:authorpubmed-author:GirardBenoitBlld:pubmed
pubmed-article:19734009pubmed:authorpubmed-author:NabboutRimaRlld:pubmed
pubmed-article:19734009pubmed:authorpubmed-author:TrouillardOri...lld:pubmed
pubmed-article:19734009pubmed:authorpubmed-author:LeguernEricElld:pubmed
pubmed-article:19734009pubmed:authorpubmed-author:SouvilleIsabe...lld:pubmed
pubmed-article:19734009pubmed:authorpubmed-author:Bahi-BuissonN...lld:pubmed
pubmed-article:19734009pubmed:authorpubmed-author:DepienneChris...lld:pubmed
pubmed-article:19734009pubmed:authorpubmed-author:AfenjarAlexan...lld:pubmed
pubmed-article:19734009pubmed:authorpubmed-author:ChipauxMathil...lld:pubmed
pubmed-article:19734009pubmed:copyrightInfo2009 Elsevier B.V. All rights reserved.lld:pubmed
pubmed-article:19734009pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19734009pubmed:volume87lld:pubmed
pubmed-article:19734009pubmed:ownerNLMlld:pubmed
pubmed-article:19734009pubmed:authorsCompleteYlld:pubmed
pubmed-article:19734009pubmed:pagination25-30lld:pubmed
pubmed-article:19734009pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:meshHeadingpubmed-meshheading:19734009...lld:pubmed
pubmed-article:19734009pubmed:year2009lld:pubmed
pubmed-article:19734009pubmed:articleTitleCDKL5 and ARX mutations are not responsible for early onset severe myoclonic epilepsy in infancy.lld:pubmed
pubmed-article:19734009pubmed:affiliationService de Neurologie Pediatrique, hôpital Necker Enfants Malades, APHP, Université Paris Descartes, Paris, France.lld:pubmed
pubmed-article:19734009pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19734009pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:6792entrezgene:pubmedpubmed-article:19734009lld:entrezgene
entrez-gene:170302entrezgene:pubmedpubmed-article:19734009lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19734009lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19734009lld:entrezgene